The U.S. Food and Drug Administration (FDA) recently held a Patient Engagement Advisory Committee meeting focused on clinical trial informed ...

"We are also pleased with the steady progress of our pipeline, which included multiple filing acceptances in Europe and the ...

Dr. Eugene Braunwald is often called the father of modern cardiology. He calls that an exaggeration. "Maybe I've been around ...

Valentina Jaramillo gives an overview of clinical research sites in Latin America. There have been discussions for a while now about the importance of developing countries in clinical research and ...

Inovio Pharmaceuticals (NASDAQ: INO) Q3 2024 Earnings Call Nov 14, 2024, 4:30 p.m. ET ...

Frailty is a strong predictor of dementia risk, with risk increasing by 40% with each 4-5 additional age-related health conditions.

One of the standout features of the Hydrogen Switch is its capacity for multiple uses per charge. After a full charge, users ...

Total Revenues in the first nine months of 2024 increased by $300 million compared to same period in 2023, to $339 million, with Q3 revenues contributing $103 millionProduct revenues in the first nine ...

CBL-514 is the first and only drug to receive EMA Orphan Drug Designation for Dercum's disease treatment. - CBL-514 received both FDA Orphan Drug Designation and Fast Track designation for Dercum's ...

We created a 5-minute and a 10-minute video. The videos provide 1) an overview of clinical research, 2) considerations for participating in clinical trials, and 3) reasons to participate. Researchers ...

EBP is the cornerstone of clinical practice ... research evidence appraisal tool, non-research evidence appraisal tool, individual evidence summary tool, synthesis process and recommendations tool, ...